HIC1 suppresses Tumor Progression and Enhances CD8 + T Cells Infiltration Through Promoting GSDMD‐induced Pyroptosis in Gastric Cancer
Advanced Science · 2025-07 · 12 (26)
DOI: 10.1002/advs.202412083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.04.2025. Verfasst von Mengjie Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Basic Medical Sciences, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Pyroptosis, CD8-Positive T-Lymphocytes, Phosphate-Binding Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate Student Scientific Research Innovation Projects in Jiangsu Province, Xuzhou Key Research and Development Projects.
Abstract (Originalsprache)
Recently, immune checkpoint blockade treatment has made remarkable strides in combatting malignancies, including gastric cancer (GC). Nonetheless, the efficacy of immunotherapy in GC patients remains constrained, warranting further exploration of the underlying molecular mechanisms to improve therapeutic outcomes. Hypermethylated in cancer 1 (HIC1) is acknowledged as a transcriptional regulator crucial for multiple aspects of cell development, yet its role in antitumor immune responses remains incompletely understood. This investigation reveals a significant downregulation of HIC1 in gastric cancer, correlating with a less favorable prognosis. Overexpression of HIC1 promotes the initiation of cell pyroptosis. Mechanistically, gasdermin D (GSDMD), a pivotal executor of pyroptosis, is identified as a downstream target of HIC1 and activated by HIC1 at the transcriptional level. Subsequent cleavage of the GSDMD N‐terminal region punctures the cell membrane, instigating pyroptosis and releasing inflammatory factors. Furthermore, HIC1 augments the infiltration of CD8 + T cells to counteract immune evasion. The combinatorial approach of HIC1 overexpression with PD‐L1 antibody demonstrates a synergistic therapeutic impact in treating GC. Additionally, c‐Jun activation domain‐binding protein 1 (Jab1) mediates the ubiquitylation and proteasomal degradation of HIC1 at Lys 517 . Ultimately, these findings underscore the potential of HIC1 as a promising immunotherapeutic target for the treatment of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Basic Medical Sciences, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
- Department of Anatomy, School of Basic Medical Sciences, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
ORCID-Profile: Dongsheng Pei
Förderung
- Graduate Student Scientific Research Innovation Projects in Jiangsu Province
- Xuzhou Key Research and Development Projects
Zitieren
APA
Kang, M., Du, W., Ding, L., Wu, M., & Pei, D. (2025). HIC1 suppresses Tumor Progression and Enhances CD8 + T Cells Infiltration Through Promoting GSDMD‐induced Pyroptosis in Gastric Cancer. Advanced Science, 12(26). https://doi.org/10.1002/advs.202412083
Vancouver
Kang M, Du W, Ding L, Wu M, Pei D. HIC1 suppresses Tumor Progression and Enhances CD8 + T Cells Infiltration Through Promoting GSDMD‐induced Pyroptosis in Gastric Cancer. Advanced Science. 2025;12(26). doi:10.1002/advs.202412083
BibTeX
@article{Kang2025,
author = {Kang, Mengjie and Du, Wenqi and Ding, Lina and Wu, Mengdi and Pei, Dongsheng},
title = {HIC1 suppresses Tumor Progression and Enhances CD8 + T Cells Infiltration Through Promoting GSDMD‐induced Pyroptosis in Gastric Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {26},
doi = {10.1002/advs.202412083}
}
EUVIMED